Aminosalicylic acid reduces the antiproliferative effect of hyperglycaemia, advanced glycation endproducts and glycated basic fibroblast growth factor in cultured bovine aortic endothelial cells: Comparison with aminoguanidine

Molecular and Cellular Biochemistry

Volumn 246, Issue 1-2, 2003, Pages 143-153

  Duraisamy, Yasotha ^a   Gaffney, John ^a   Slevin, Mark ^a   Smith, Christopher A ^a   Williamson, Kenneth ^a   Ahmed, Nessar ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Advanced glycation endproducts; Aminoguanidine; Aminosalicylic acid; Antioxidants; Basic fibroblast growth factor; Free radicals; Glycation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; AMINOGUANIDINE; AMINOSALICYLIC ACID; ANTIOXIDANT; BASIC FIBROBLAST GROWTH FACTOR; BOVINE SERUM ALBUMIN; DEFEROXAMINE; DIMETHYL SULFOXIDE; GLUCOSE; TAURINE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; CATTLE; CELL CULTURE; CELL PROLIFERATION; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENDOTHELIUM CELL; GLYCATION; HYPERGLYCEMIA; MITOGENESIS; NONHUMAN; REVIEW;

AMINOSALICYLIC ACIDS; ANIMALS; CATTLE; CELL DIVISION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; GLUCOSE; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0037741359     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023470921116     Document Type: Review

References (49)

1. Giardino I, Edelstein D, Brownlee M: Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. J Clin Invest 94: 110-117, 1994
2. Lorenzi M, Cagliero E, Toledo S: Glucose toxicity for human endothelial cells in culture: Delayed replication, disturbed cell cycle and accelerated death. Diabetes 34: 621-627, 1985
3. Curcio F, Ceriello A: Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: New insights on the pathophysiological mechanisms of diabetic vascular complications. In Vitro Cell Dev Biol 28A: 787-790, 1992
4. Kamal K, Du W, Mills I, Sumpio BE: Antiproliferative effect of elevated glucose in human microvascular endothelial cells. J Cell Biochem 71: 491-501, 1998
5. La Selva M, Beltramo E, Pagnozzi F, Bena E, Molinatti PA, Molinatti GM, Porta M: Thiamine corrects delayed replication and decreases production of lactate and advanced glycation endproducts in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions. Diabetologia 39: 1263-1268, 1996
6. Lorenzi M, Nordberg JA, Toledo S: High glucose prolongs cell cycle traversal of cultured human endothelial cells. Diabetes 36: 1261-1267, 1987
7. Brownlee M: Glycation and diabetic complications. Diabetes 43: 836-841, 1994
8. Hunt JV, Dean RT, Wolf SP: Hydroxyl radical production and autoxidative glycosylation: Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J 256: 205-212, 1988
9. Hunt JV, Bottoms MA, Mitchinson MJ: Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Biochem J 291: 529-535, 1993
10. Chibber R, Molinatti PA, Kohner EM: Intracellular protein glycation in cultured retinal capillary pericytes and endothelial cells exposed to high glucose concentration. Cell Mol Biol 45: 47-57, 1999
11. Maciag T, Hoover GA, Stemerman MB, Weinstein R: Serial propagation of human endothelial cells in vitro. J Cell Biol 91: 420-426, 1981
12. Schweigerer L, Neufeld G, Friedman J, Abraham JA, Fiddes JC, Gospodarowicz D: Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 325: 257-259, 1987
13. Muthukrishnan L, Warder E, McNeil PL: Basic fibroblast growth factor is efficiently released from a cytosolic storage site through plasma membrane disruptions of endothelial cells. J Cell Physiol 148: 1-16, 1991
14. Beutler E: Glycosylation of haemoglobin in diabetics. Dev Biochem 9: 489-492, 1980
15. Trachtman H, Futterweit S, Prenner J, Hanon S: Antioxidants reverse the antiproliferative effect of high glucose and advanced glycosylation endproducts in cultured rat mesangial cells. Biochem Biophys Res Commun 199: 346-352, 1994
16. Chibber R, Molinatti PA, Rosatto N, Lambourne B, Kohner EM: Toxic action of advanced glycation endproducts on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy. Diabetologia 43: 156-164, 1997
17. Bucala R, Vlassara H: Advanced glycosylation endproducts in diabetic renal and vascular disease. Am J Kidney Dis 26: 875-888, 1995
18. Schmidt A-M, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, Esposito C, Hegarty H, Hurley W, Clauss M, Wang F, Pan Y-C, Tsang T, Stern D: Isolation and characterisation of binding proteins for advanced glycation endproducts from lung tissue which are present on the endothelial cell surface. J Biol Chem 267: 14987-14997, 1992
19. Yan S-D, Schmidt A-M, Anderson GM, Zhang J, Brett J, Zou Y-S, Pinsky D, Stern D: Enhanced cellular oxidant Stress by the interaction of advanced glycation endproducts with their receptors/binding proteins. J Biol Chem 269: 9889-9897, 1994
20. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M: Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 88: 11555-11558, 1991
21. Swamy-Mruthinti S, Green K, Abraham EC: Inhibition of cataracts in moderately diabetic rats by aminoguanidine. Exp Eye Res 62: 505-510, 1996
22. Ellis EN, Good BH: Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus. Metabolism 40: 1016-1019, 1991
23. Soulis T, Cooper ME, Vranes D, Bucala R, Jerums G: Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment. Kidney Int 50: 627-634, 1996
24. Yagihashi S, Kamijo M, Baba M, Yagihashi N, Nagai K: Effect of aminoguanidine on functional and structural abnormalities in peripheral nerves of STZ-induced diabetic rats. Diabetes 41: 47-52, 1992
25. Chibber R, Molinatti PA, Wong JSK, Mirlees D, Kohner EM: The effect of aminoguanidine and tolrestat on glucose toxicity in bovine retinal capillary pericytes. Diabetes 43: 758-763, 1994
26. Teixeira AS, Andrade SP: Glucose-induced inhibition of angiogenesis in the rat sponge granuloma is prevented by aminoguanidine. Life Sci 64: 655-662, 1999
27. Lewis BS, Harding JJ: The effects of aminoguanidine on the glycation (non-enzymic glycosylation) of lens protein. Exp Eye Res 50: 463-467, 1990
28. Bucala R, Vlassara H: Advanced glycosylation endproducts in diabetic renal disease: Clinical measurement, pathophysiological significance and prospects for pharmacological inhibition. Blood Purif 13: 160-170, 1995
29. Courderot-Masuyer C, Dalloz F, Maupoil V, Rochette L: Antioxidant properties of aminoguanidine. Fund Clin Pharmacol 13: 535-540, 1999
30. Kumari K, Umar S, Bansal V, Sahib MK: Inhibition of diabetes-associated complications by nucleophilic compounds. Diabetes 40: 1079-1084, 1991
31. Corbett JA, Tilton RG, Cheng K, Hasan KS, Iodo Y, Wang JC, Sweetland MA, Lancaster JR, Williamson JR, McDaniel ML: Aminoguanidine a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41: 552-556, 1992
32. Tasaka Y, Nakaya F, Matsumoto H: Effects of aminoguanidine on insulin release from pancreatic islets. Endocrine J 41: 309-313, 1994
33. Cosio FG: Effects of high glucose concentrations on human mesangial cell proliferation. J Am Soc Nephrol 5: 1600-1609, 1995
34. Ou P, Wolff SP: Aminoguanidine: A drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro. Biochem Pharmacol 46: 1139-1144, 1992
35. Simmonds NJ, Millar AD, Blake DR, Rampton DS: Antioxidant effects of aminosalicylates and potential new drugs for inflammatory bowel disease: Assessment in cell-free systems and inflamed human colorectal biopsies. Aliment Pharmacol Ther 13: 363-372, 1999
36. Sattar A, Kumar S, West DC: Does hyaluronan have a role in endothelial cell proliferation of the synovium? Semin Arthritis Rheum 22: 37-43, 1992
37. Porta M, La Selva M, Bertagna A, Mohinatti GM: High glucose concentrations inhibit DNA synthesis and replication without causing death or impairing injury repair in cultured human endothelial cells. Diabetes Res 7: 59-63, 1988
38. McDermott AM, Kern TS, Murphy CJ: The effect of elevated extracellular glucose on migration, adhesion and proliferation of SV4O transformed human corneal epithelial cells. Curr Eye Res 17: 924-932, 1998
39. Giardino I, Edelstein D, Brownlee M: BCL-2 expression or antioxidants prevent hyperglycaemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J Clin Invest 97: 1422-1428, 1996
40. Brownlee M, Vlassara H, Cerami A: Nonenzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasmin. Diabetes 32: 680-684, 1983
41. Thornally P, Wolff S, Crabbe J, Stern A: The autoxidation of glyceraldehyde and other simple monosaccharides under physiological conditions catalysed by buffer ions. Biochim Biophys Acta 797: 276-287, 1984
42. Nissen NN, Shankar R, Gamelli RL, Singh A, DiPietro LA: Heparin and heparin sulphate protect basic fibroblast growth factor from non-enzymic glycosylation. Biochem J 338: 637-642, 1999
43. McCarthy A, Etcheverry SB, Bruzzone L, Cortizo AM: Effects of advanced glycation endproducts on the proliferation and differentiation of osteoblast-like cells. Mol Cell Biochem 170: 43-51, 1997
44. Cameron NE, Cotter MA, Dines K, Love A: Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 35: 946-950, 1992
45. Teixeira AS, Caliari MV, Rocha OA, Machado RD, Andrade SP: Aminoguanidine prevents impaired healing and deficient angiogenesis in diabetic rats. Inflammation 23: 569-581, 1999
46. Booth AA, Khalifah RG, Hudson BG: Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation endproducts: Comparison with aminoguanidine. Biochem Biophys Res Commun 220: 113-119, 1996
47. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412, 1991
48. Duraisamy Y, Slevin M, Smith N, Bailey J, Zweit J, Smith C, Ahmed N, Gaffney J: Effect of glycation on basic fibroblast growth factor induced angiogenesis and activation of associated signal transduction pathways in vascular endothelial cells: Possible relevance to wound healing in diabetes. Angiogenesis 4: 277-288, 2001
49. Hipkiss AR, Carnosine, a protective, anti-ageing peptide? Int J Biochem Cell Biol 30: 863-868, 1998